Drug Markets/Elbasvir and Grazoprevir

Elbasvir and Grazoprevir

1 NDC across 1 manufacturer|0 Generic,1 Brand

▸ More about this market

Elbasvir and Grazoprevir is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $634.24 to $634.24 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

0G / 1B

Manufacturers

competing in market

Price Spread

$634.24 – $634.24

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing ELBASVIR AND GRAZOPREVIR

Merck Sharp & Dohme LLC

1 NDC

$634.2375

avg/unit

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
ZEPATIER 50-100 MG TABLET	00006307402	Merck Sharp & Dohme LLC	$634.2375 per EA	—	Brand	—	Hepatitis C Virus NS3/4A Protease Inhibitor, Hepatitis C Virus NS5A Inhibitor

Frequently Asked Questions

How many Elbasvir and Grazoprevir products are on the market?

The Elbasvir and Grazoprevir drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Elbasvir and Grazoprevir?

NADAC reference prices for Elbasvir and Grazoprevir range from $634.2375 to $634.2375 per EA.

Which manufacturers make Elbasvir and Grazoprevir?

1 manufacturer lists Elbasvir and Grazoprevir in NADAC. Ranked by number of NDCs, the largest are Merck Sharp & Dohme LLC (1).